1. Home
  2. ADPT vs GABC Comparison

ADPT vs GABC Comparison

Compare ADPT & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • GABC
  • Stock Information
  • Founded
  • ADPT 2009
  • GABC 1910
  • Country
  • ADPT United States
  • GABC United States
  • Employees
  • ADPT N/A
  • GABC N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • GABC Major Banks
  • Sector
  • ADPT Health Care
  • GABC Finance
  • Exchange
  • ADPT Nasdaq
  • GABC Nasdaq
  • Market Cap
  • ADPT 1.2B
  • GABC 1.2B
  • IPO Year
  • ADPT 2019
  • GABC N/A
  • Fundamental
  • Price
  • ADPT $8.27
  • GABC $39.27
  • Analyst Decision
  • ADPT Buy
  • GABC Buy
  • Analyst Count
  • ADPT 5
  • GABC 4
  • Target Price
  • ADPT $9.10
  • GABC $46.00
  • AVG Volume (30 Days)
  • ADPT 1.4M
  • GABC 128.2K
  • Earning Date
  • ADPT 02-11-2025
  • GABC 01-27-2025
  • Dividend Yield
  • ADPT N/A
  • GABC 2.95%
  • EPS Growth
  • ADPT N/A
  • GABC N/A
  • EPS
  • ADPT N/A
  • GABC 2.83
  • Revenue
  • ADPT $178,957,000.00
  • GABC $250,476,000.00
  • Revenue This Year
  • ADPT $20.07
  • GABC N/A
  • Revenue Next Year
  • ADPT $25.27
  • GABC $7.67
  • P/E Ratio
  • ADPT N/A
  • GABC $14.09
  • Revenue Growth
  • ADPT 5.10
  • GABC 0.94
  • 52 Week Low
  • ADPT $2.28
  • GABC $30.66
  • 52 Week High
  • ADPT $8.95
  • GABC $47.08
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 58.94
  • GABC 39.78
  • Support Level
  • ADPT $8.09
  • GABC $39.91
  • Resistance Level
  • ADPT $8.69
  • GABC $40.96
  • Average True Range (ATR)
  • ADPT 0.64
  • GABC 0.85
  • MACD
  • ADPT -0.00
  • GABC -0.11
  • Stochastic Oscillator
  • ADPT 65.66
  • GABC 4.24

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The Company's lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

Share on Social Networks: